ProjectREGAIN – I5Q-MC-CGAI
Basic data
Acronym:
REGAIN
Title:
I5Q-MC-CGAI
Duration:
25/11/2015 to 24/11/2017
Abstract / short description:
A phase 3, randomized, double-blind, placebo-controlled study of LY2951742 in patients with chronic migraine - the REGAIN study.
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology and Epileptology
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Basingstoke, Hampshire, United Kingdom